Molecule Name |
DB08450
|
DrugBank Groups |
Experimental
|
Cluster No |
1474
|
Smiles |
N=1(C(=NC4(=CC=CC=C4(C=1NC3(=CC2(=C(NN=C2)C=C3)))))C5(=NC(=CC=C5)C))
|
Download |
mol2, pdbqt
|
TPSA |
270,31
|
Non-H Atoms |
27
|
Non-C/H Atoms |
6
|
Metal-Atoms |
0
|
Electronegative Atoms |
6
|
Stereo Centers |
0
|
Rotatable Bonds |
3
|
Rings Closures |
5
|
Small Rings |
5
|
Aromatic Rings |
5
|
Aromatic Atoms |
25
|
sp3-Atoms |
1
|
Symmetric atoms |
0
|
cLogS |
-5,7
|
MW |
352,4
|
cLogP |
3,6366
|
HBA |
6
|
HBD |
2
|
Ro5 violations |
0
|
Druglikeness |
2,3781
|
DrugScore |
0,531077097976004
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-2,6154
|
Caco-2 Permeability 2 |
0,9492
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,4302
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,6282
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,3982
|
Carcinogenicity (Three-class) |
Danger
|